PepGen Inc. PEPG 深 滬
等待開盤 06-18 09:30:00 美东时间
1.70
+0.110
+6.92%
華盛通- 最 高1.78
- 今 開1.61
- 成交量 125.62万股
- 最 低 1.595
- 昨 收 1.59
- 總市值 1.18亿
- 52周最高 7.80
- 市盈率 靜 --
- 換手率 1.82%
- 52周最低 1.01
- 委 比 11.23%
- 總股本 6916.92万
- 歷史最高 20.00
- 量 比 2.12
- 振 幅 11.64%
- 歷史最低 0.8801
- 每 手 1
- 風險率 2.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅117.92%！摩根大通上调Camp4 Therapeutics目标价至9美元，维持"超配"评级
今日重点评级关注：摩根大通：上调Camp4 Therapeutics评级至"超配"，目标价从5美元升至9美元；Canaccord Genuity：维持Rhythm制药"买入"评级，目标价从143美元升至151美元
06-17 11:32
Craig-Hallum Initiates Coverage On PepGen with Buy Rating, Announces Price Target of $11
Craig-Hallum analyst Adam Vogel initiates coverage on PepGen (NASDAQ:PEPG) with a Buy rating and announces Price Target of $11.
06-16 22:33
PepGen To Highlight Data From PGN-EDODM1 Program In Poster And Late-Breaking Oral Presentation At IDMC-15
PepGen Inc. (NASDAQ:PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases,
05-21 19:04
PepGen Files Prospectus To Offer Up To $400M Of Common Stock
https://www.sec.gov/Archives/edgar/data/1835597/000119312526228960/d132482ds3.htm
05-20 00:09
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
Wedbush Maintains Outperform on PepGen, Lowers Price Target to $4
Wedbush analyst Laura Chico maintains PepGen (NASDAQ:PEPG) with a Outperform and lowers the price target from $5 to $4.
05-13 22:41
PepGen Q1 EPS $(0.26) Beats $(0.31) Estimate
PepGen (NASDAQ:PEPG) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 71.74 percent increase over losses of $(0.92) per share from the same
05-13 05:06
Top 3 Health Care Stocks Which Could Blast Off This Quarter
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)
04-08 18:40
美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
Why Is PepGen Stock Sinking Tuesday?
PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.
03-31 19:14
